Acinetobacter baumannii (IMAGE)
Caption
Researchers modified a drug that was previously effective only against Gram-positive bacteria to fight Gram-negative bacteria. The redesigned drug , Debio-1452-NH3, increased survival in septic mice infected with Acinetobacter baumannii, pictured, Klebsiella pneumoniae and Escherichia coli.
Credit
Graphic by Michael B. Vincent
Usage Restrictions
May be used with stories about the research described here. Credit required: Graphic by Michael B. Vincent
License
Licensed content